Al Rajhi Holding Group

Al Rajhi Holding Group is a prominent Saudi Arabian conglomerate with a significant and expanding presence in the healthcare and life sciences sectors. Through its pharmaceutical subsidiary, Al Rajhi Pharma (Al-Rajhi Pharmaceutical Company), the group focuses on localizing the production of advanced therapies, including biosimilars, oncology treatments, and high-potency oral solid dosage forms. The company operates a modular, state-of-the-art manufacturing facility in King Abdullah Economic City (KAEC) and has established strategic partnerships with global leaders like Biocon Biologics to distribute critical medicines such as insulin glargine. Additionally, the group is a major investor in the National Medical Care Company (CARE), which manages several leading hospitals in the Kingdom, thereby covering a full spectrum of healthcare services from drug manufacturing to clinical care in alignment with Saudi Vision 2030.